Zdrowie i gospodarka · 27/07/2026

FDA Classifies Non-Medicated Topical Formulation for Erectile Dysfunction into Class II

The FDA has classified the non-medicated topical formulation for treating erectile dysfunction into Class II, a move aimed at ensuring the device's safety and effectiveness while reducing regulatory burdens, ultimately enhancing patients' access to innovative treatments.